Abstract
As molecular testing becomes further integrated into the clinical diagnostic laboratory, molecular assays and platforms continue to be validated and approved by the US Food and Drug Administration (FDA). This chapter is focused on the currently available, FDA-approved molecular diagnostic assays for sexually transmitted pathogens including Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex viruses I and II, and human papillomavirus; viral respiratory pathogens including influenza and respiratory syncytial virus; and Staphylococcus aureus and hepatitis B virus.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (WHO). Sexually transmitted infections fact sheet. Available at http://www.who.int/mediacentre/factsheets/fs110/en/. Accessed 17 June 2011.
US Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2008. Atlanta: US Department of Health and Human Services, CDC; 2009.
Holmes K. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Press; 1999.
Stamper PD, et al. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol. 2007;45(7):2191–6.
Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82–9.
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–63.
Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253–73.
Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291(11):1368–79.
Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr Opin Crit Care. 2010;16(5):460–4.
CDC. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(15):400–2.
Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med. 2009;361(2):115–9.
Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007;167(4):354–60.
Harper SA, et al. Seasonal influenza in adults and children–diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003–32.
Grijalva CG, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics. 2007;119(1):e6–11.
Rashid H, et al. Value of rapid testing for influenza among Hajj pilgrims. Travel Med Infect Dis. 2007;5(5):310–3.
Uyeki TM, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis. 2009;48(9):e89–92.
Moscicki AB, et al. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24 Suppl 3:S3/42–51.
Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer. 2007;111(3):145–53.
Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
Munoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.
Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370(9605):2127–37.
Tronstein E, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305(14):1441–9.
Okamoto H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988;69(Pt 10):2575–83.
Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis. 1991;11(2):73–83.
Krugman S. Incubation period of type B hepatitis. N Engl J Med. 1979;300(11):625.
Biswas R, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 2003;43(6):788–98.
Weinbaum CM, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1–20.
Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med. 2007;131(5):702–7.
Zou S, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009;49(8):1609–20.
Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther. 2006;10(2):77–91.
Stramer SL, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011;364(3):236–47.
Ross JS. Economic, regulatory, and practice issues in molecular pathology and diagnostics. Am J Clin Pathol. 1999;112(1 Suppl 1):S7–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
McGowin, C.L., Rohde, R.E., Whitlock, G.C. (2012). Other Pathogens of Significant Public Health Concern. In: Hu, P., Hegde, M., Lennon, P. (eds) Modern Clinical Molecular Techniques. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2170-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2170-2_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2169-6
Online ISBN: 978-1-4614-2170-2
eBook Packages: MedicineMedicine (R0)